Cite

HARVARD Citation

    van Vollenhoven, R. et al. (n.d.). SAT0199 An estimate of the proportion of patients with sle receiving off-label treatment with rituximab in european countries. Annals of the rheumatic diseases. p. 539. [Online]. 
  
Back to record